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Endometriosis is a frequent benign disorder. Malignancy arising in extraovarian endometriosis is a rare event. A 49-year-
old woman is presented with a large painful abdominal wall mass. She underwent a myomectomy, 20 years before, for
uterus leiomyoma. Computed tomography suggested that this was a desmoid tumor and she underwent surgery. Histological
examination showed a clear cell adenocarcinoma associated with endometriosis foci. Pelvic ultrasound, computed tomography,
and endometrial curettage did not show any malignancy or endometriosis in the uterus and ovaries. Adjuvant chemotherapy was
recommended, but the patient was lost to follow up. Six months later, she returned with a recurrence of the abdominal wall mass.
She was given chemotherapy and then she was reoperated.
Copyright © 2008 Thouraya Achach et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Endometriosis is a frequent benign disorder. Several obser-
vations of the coexistence of endometriosis and cancer have
been published [1, 2]. Malignancy arising in extraovarian
endometriosis is a rare event [1]. Here, we report a case
of clear cell adenocarcinoma derived from pathologically
conﬁrmed endometriosis in the abdominal wall. We dis-
cuss the epidemiological and clinicopathological features of
malignancy arising in abdominal wall endometriosis.
2.CaseReport
A 49 year-old woman, gravida 3, para 0, underwent a
myomectomy, 20 years before, for uterus leiomyoma through
a midline incision. She is presented with a painful large
abdominal wall mass. On physical examination, a ﬁrm
indurated mass was palpated in the lower abdominal wall.
Abdominal and pelvic ultrasounds followed by computed
tomography showed a heterogeneous intramuscular mass
of 8.5cm diameter without local extension (Figure 1). The
clinical impression was of desmoid tumor and the patient
takentosurgeryandthetumorwasresectedwithoutrupture.
The surgeon did not perform any peritoneal washing or
biopsies because of the absence of widespread tumor in
the peritoneal cavity. The surgical specimen consisted of
11cm cutaneous and muscular tissues, occupied by ill-
deﬁned white tumor, which contained cystic cavities and
abundant foci of necrosis. Surgical margins were positive.
Microscopically, the tumor showed a predominant papillary
and tubulocystic growth pattern (Figure 2). The tumor cells
were round or polygonal most with hobnail conﬁgura-
tion (Figure 3). The cytoplasm was clear, and the nuclei
were round with prominent nucleoli. Cellular atypia was
moderate, and mitosis was rare. Benign endometriotic foci
were observed in the proximity of the tumor (Figure 4).
Immunohistochemically, tumor cells showed diﬀuse and
strong cytoplasmic positivity with vimentin, epithelial mem-
brane antigen, and cytokeratin 7, but no staining for
cytokeratin 20 progesterone and estrogen receptor. Cal-
retinin and mesothelin were negative. Pelvic ultrasound
and computed tomography identiﬁed normal-sized ovaries
and uterus. Endometrial curettage was negative for malig-
nancy.
The diagnosis of clear cell adenocarcinoma arising
from abdominal endometriosis foci was retained. Adjuvant2 Journal of Oncology
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Figure 1: Computed tomograms of the abdomen show a heteroge-
neous and ill-deﬁned tumor in the abdominal wall.
Figure 2: Tubulocystic and papillary pattern (hematoxylin eosin,
original magniﬁcation ×200).
chemotherapy was indicated, but the patient was lost to
follow up. She returned six months after. At that time,
ultrasound and computed tomography showed a recurrent
mass at the abdominal wall with extension to the bladder.
Three cycles of combination chemotherapy with cyclophos-
phamide and cisplatin were given, but the tumor did not
regress.Sheunderwentsurgeryagainwitharesectionof5cm
encapsulated nodule. At that time, uterus, ovaries, and tubes
did not show any abnormalities. Histology demonstrated
the same type of tumor. Margins were free of tumor. Three
cycles of chemotherapy were also given but failed to control
the disease; the chemotherapy she got is not precised. The
computed tomography showed again a recurrent mass with
extension to the bladder and pelvic bone, and adjuvant
radiotherapy was indicated.
3. Discussion
Endometriosis, deﬁned as the presence of endometrial-like
tissue outside the uterine cavity, is usually located in the
ovaries and pelvic peritoneum [2, 3]. Parietal endometriosis
is very rare and constitutes 1 to 2% of endometriosis cases
[1]. It arises usually in a surgical scar of cesarean section
or hysterectomy, and less frequently in a surgical scar of
hernia or of appendicectomy [1, 4]. Cases of endometriosis
without scar have been described [1]. The incidence of
Figure 3: Tumor cells with hobnail conﬁguration (hematoxylin
eosin, original magniﬁcation ×400).
Figure 4: Endometrial gland invaded by tumor cells (hematoxylin
eosin, original magniﬁcation ×400).
abdominal wall endometriomas is of 0.04% among parturi-
ents undergoing cesarean section and it is more frequent
than endometriosis following conventional gynaecologic
surgery [4, 5]. In our case, abdominal wall endometriosis
occurred in a surgical midline scar of myomectomy. The
etiopathogenetic mechanism is more likely related to iatro-
genic transplantation of endometrium during gynecological
surgery rather than hematogenous dissemination or meta-
plasia [4, 6]. Clinical diagnosis remains diﬃcult, and many
patients are asymptomatic [4]. Symptoms related to pelvic
endometriosis are noted in 26% of cases. Ultrasound can
show a cystic lesion in many cases [5]. Women with pelvic
endometriosis have a higher frequency of malignancy, but
malignantchangeinextrapelvicendometriosisisarareevent
[1, 2, 4, 7]. Twenty percent of malignancy in endometriosis
occurs in extragonadal site [1, 8, 9] .T h e r ei se x t e n s i v ec l i n -
icopathological, molecular, and genetic evidence supporting
thehypothesisthatendometriosisisaneoplasticprocesswith
a potential for malignant transformation [3]. The natural
course of malignant transformation of endometriosis is long
and can be explained by estrogenic stimulation [8, 10–
12]. Malignant transformation in endometriosis was ﬁrst
described by Sympson in 1925 in [9], who proposed three
criteriafordiagnosis:demonstrationofaclearexampleofthe
endometriosis in proximity to the tumor, no other primary
site for the tumor, and histologic appearance consistent with
an origin from endometriosis. Scott in [1, 8] recommended
the presence of transitional area between endometriosisJournal of Oncology 3
and cancer. Atypical endometriosis, a term ﬁrst coined by
LaGrenade and Silvergerg in 1988 in [8, 13], is rare and
is characterized by endometriotic glands with cytological
and/or architectural atypia (hyperchromatic or pale nuclei
with moderate to marked pleomorphism increased nuclear
to cytoplasmic ratio, cellular crowding, stratiﬁcation, or
tufting). The rate of atypical endometriosis ranges from
1 . 7t o3 . 6 %i no v a r i a ne n d o m e t r i o s i s[ 13]. Fukunaga et al.
[13] demonstrated that atypical endometriosis in ovary is
often associated with epithelial neoplasm and showed direct
transition from atypical epithelium to malignant tumor. In
our case, the criteria of Sympson were fully satisﬁed. The
demonstration of endometriosis might require the examina-
tion of multiple levels and sections, that is why preoperative
biopsy cannot make the diagnosis of malignancy arising in
endometriosis [6]. Tumors that can arise in endometriosis
include in decreasing order: endometrio id carcinoma (75.9–
69.1%), sarcoma (25–11.6%), clear cell carcinoma (13.5–
4.5%), and mucinous or serous carcinoma (4.6%–1%) [4].
In extrapelvic localization, clear cell carcinoma is the most
common histological subtype, followed by endometrioid
carcinoma[1].Duetotherarityofmalignanttransformation
of endometriosis at extragonadal sites, it is diﬃcult to
establishatreatmentprotocol.First-linetreatmentissurgery,
removing as much endometriosis as possible, staging at
this point is also necessary. Second-line treatment, with
chemotherapy,radiotherapy,andevenhormonotherapymay
be needed. Prognosis is variable from 10 to 100% ﬁve-year
survival, depending on histological type and localization of
the disease [7].
4. Conclusion
Cutaneous localization of endometriosis is unusual and
appears most frequently in surgical scars from obstetric or
gynecological interventions. It is important to recognize the
possibility of tumors arising from endometriosis when the
pathologist is confronted to an extraovarian tumor with
endometrial appearance. Examination of multiple sections is
required to demonstrate endometriosis foci.
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